These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 22705361)
21. Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF(165) in the brain. Heinzer S; Kuhn G; Krucker T; Meyer E; Ulmann-Schuler A; Stampanoni M; Gassmann M; Marti HH; Müller R; Vogel J Neuroimage; 2008 Feb; 39(4):1549-58. PubMed ID: 18077185 [TBL] [Abstract][Full Text] [Related]
22. Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method. Zheng X; Wise SM; Cristini V Bull Math Biol; 2005 Mar; 67(2):211-59. PubMed ID: 15710180 [TBL] [Abstract][Full Text] [Related]
23. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. Abramovitch R; Dafni H; Smouha E; Benjamin LE; Neeman M Cancer Res; 1999 Oct; 59(19):5012-6. PubMed ID: 10519416 [TBL] [Abstract][Full Text] [Related]
24. Angiopoietin-2 inhibits the growth of tongue carcinoma without affecting expression of vascular endothelial growth factor. Chen HH; Chai L; Wang SQ; Shi ZJ; Wu QL Int J Oral Maxillofac Surg; 2011 Jun; 40(6):628-32. PubMed ID: 21163623 [TBL] [Abstract][Full Text] [Related]
25. Using behavioral measurement to assess tumor progression and functional outcome after antiangiogenic treatment in mouse glioma models. Yang H; Chopp M; Zhang X; Jiang F; Zhang Z; Kalkanis S; Schallert T Behav Brain Res; 2007 Aug; 182(1):42-50. PubMed ID: 17572515 [TBL] [Abstract][Full Text] [Related]
26. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach. Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451 [TBL] [Abstract][Full Text] [Related]
27. Vascular network remodeling via vessel cooption, regression and growth in tumors. Bartha K; Rieger H J Theor Biol; 2006 Aug; 241(4):903-18. PubMed ID: 16545398 [TBL] [Abstract][Full Text] [Related]
28. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. Ke LD; Shi YX; Im SA; Chen X; Yung WK Clin Cancer Res; 2000 Jun; 6(6):2562-72. PubMed ID: 10873113 [TBL] [Abstract][Full Text] [Related]
29. Towards whole-organ modelling of tumour growth. Alarcón T; Byrne HM; Maini PK Prog Biophys Mol Biol; 2004; 85(2-3):451-72. PubMed ID: 15142757 [TBL] [Abstract][Full Text] [Related]
30. Continuous and discrete mathematical models of tumor-induced angiogenesis. Anderson AR; Chaplain MA Bull Math Biol; 1998 Sep; 60(5):857-99. PubMed ID: 9739618 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system. Miraux S; Lemière S; Pineau R; Pluderi M; Canioni P; Franconi JM; Thiaudière E; Bello L; Bikfalvi A; Auguste P Angiogenesis; 2004; 7(2):105-13. PubMed ID: 15516831 [TBL] [Abstract][Full Text] [Related]
32. A mathematical model for the capillary endothelial cell-extracellular matrix interactions in wound-healing angiogenesis. Olsen L; Sherratt JA; Maini PK; Arnold F IMA J Math Appl Med Biol; 1997 Dec; 14(4):261-81. PubMed ID: 9415995 [TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Plate KH; Breier G; Weich HA; Risau W Nature; 1992 Oct; 359(6398):845-8. PubMed ID: 1279432 [TBL] [Abstract][Full Text] [Related]
34. Mathematical modelling, simulation and prediction of tumour-induced angiogenesis. Chaplain MA; Anderson AR Invasion Metastasis; 1996; 16(4-5):222-34. PubMed ID: 9311387 [TBL] [Abstract][Full Text] [Related]
35. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
36. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model. Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975 [TBL] [Abstract][Full Text] [Related]
37. A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites. Bernsen HJ; Rijken PF; Hagemeier NE; van der Kogel AJ Microvasc Res; 1999 May; 57(3):244-57. PubMed ID: 10329251 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain. Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896 [TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages. Linde N; Lederle W; Depner S; van Rooijen N; Gutschalk CM; Mueller MM J Pathol; 2012 May; 227(1):17-28. PubMed ID: 22262122 [TBL] [Abstract][Full Text] [Related]
40. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]